MAR 07, 2017 06:57 PM PST

Another Step Forward in the Fight Against Breast Cancer

WRITTEN BY: Carmen Leitch

Cancer is most deadly when it spreads from the part of the body where it formed to another part, metastasis. Breast cancer patients are killed not because of breast cancer recurrence, but because it metastasizes; migration to the brain is deadliest for the patient. Researchers at City of Hope have learned more about brain metastases in women suffering from HER-2 positive breast cancer. Around 40 percent of HER-2 positive breast cancers (explained in the video below from the Dana-Farber Cancer Institute) go on to experience brain metastases. Understanding more about the mechanism behind this event will help inform new treatments.

"More women than ever are surviving breast cancer only to die from breast tumors growing in their brains years after they've been declared cancer-free," explained the leader of the study,  Rahul Jandial, M.D., Ph.D., a neurosurgeon and scientist at City of Hope. "I wanted to understand why women with HER2-positive breast cancer (around 20 percent of all breast cancers) have higher rates of brain metastases than women with other breast cancer subtypes and in turn, find their biological Achilles heel to develop new medicines." This work is set to be reported in Clinical & Experimental Metastasis, the journal of the Metastases Research Society.

A protein called reelin that is typically only found in the brain, also encases breast cancer cells, which acts as a shield preventing detection of the cancerous cells. The cells are able to avoid protective mechanisms used by the brain and can then take hold. From their, a dangerous brain tumor can begin to grow.

Following brain surgery, Jandial and his team were able to use the tissue samples remaining after the surgery, comparing those specimens to breast cancer tissue obtained during mastectomies that the same patients had undergone. The investigators found that expression of the reelin protein was low in tissue from primary breast cancer, but in breast cancer that was HER-2 positive and had metastasized to the brain, reel in expression was significantly higher. 

"The cells are essentially able to act as spies that look like citizens," explained Jandial. "They release a mesh of protein and escape the brain's natural defense weapons, causing tumors to grow in the brain."

90 percent of all cancer deaths result from metastases; people that are diagnosed with metastases in the brain have only a 20 percent chance of living a year after their diagnosis. This work will hopefully help patients afflicted with cancer, especially those with metastatic breast cancer.

Metastatic Breast Cancer in Pleural Fluid / Credit: Ed Uthman/Flickr

 

Sources: AAAS/Eurekalert! via City of Hope, Clinical & Experimental Metastasis

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 21, 2019
Genetics & Genomics
OCT 21, 2019
New Drug Targets for Lung Cancer Identified
Researchers at the Salk Institute have now learned why certain genetic mutations lead to cancer growth....
OCT 21, 2019
Cancer
OCT 21, 2019
Ladies, chicken or steak?
Ladies, trying to choose between chicken or steak? New research published in the International Journal of Cancer might help you decide. According to the st...
OCT 21, 2019
Genetics & Genomics
OCT 21, 2019
Genetic Cause for Tumor Progression
Researchers from the University of Delaware (UDEL), Harvard Medical School (HMS) and University of California, Los Angeles (UCLA), have discovered a ribonu...
OCT 21, 2019
Cell & Molecular Biology
OCT 21, 2019
Stem Cell Derived Natural Killer T Cells as Novel and Long-term Cancer Treatment
Hematopoietic stem cells are used to create a population of Natural Killer T-cells that could sustain and renew within the immune system, and attack cancer cells....
OCT 21, 2019
Cancer
OCT 21, 2019
New diagnostic tool for thyroid cancer
Thyroid cancer diagnoses have risen in the last thirty years from 6 per 100,000 to more than 14 per 100,000. That’s according to the Surveillance, Ep...
OCT 21, 2019
Cell & Molecular Biology
OCT 21, 2019
Differences in Pediatric vs. Adult Cancer Force the Discussion of Effective Therapies
A team of scientists study the differences between childhood and adult cancer. This drives the discussion of the use of effective adult cancer treatments on children....
Loading Comments...